|
๐
|
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
30 auth.
G. Salles,
J. Seymour,
F. Offner,
A. Lรณpez-Guillermo,
D. Belada,
L. Xerri,
P. Feugier,
R. Bouabdallah,
J. Catalano,
P. Brice,
D. Caballero,
C. Haioun,
L. Pedersen,
A. Delmer,
D. Simpson,
...
S. Leppa,
P. Soubeyran,
A. Hagenbeek,
O. Casasnovas,
T. Intragumtornchai,
C. Fermeฬ,
Maria Gomes da Silva,
C. Sebban,
A. Lister,
J. Estell,
G. Milone,
A. Sonet,
M. Mendila,
B. Coiffier,
H. Tilly
|
9 |
2011 |
9
๐
|
|
๐
|
Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.
13 auth.
B. Coiffier,
C. Haioun,
N. Ketterer,
A. Engert,
H. Tilly,
D. Ma,
Peter Johnson,
A. Lister,
M. FeuringโBuske,
J. Radford,
...
R. Capdeville,
Volker Diehl,
F. Reyes
|
9 |
1998 |
9
๐
|
|
๐
|
Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.
17 auth.
J. Radford,
T. Illidge,
N. Counsell,
B. Hancock,
R. Pettengell,
P. Johnson,
J. Wimperis,
D. Culligan,
B. Popova,
Paul Smith,
...
A. McMillan,
A. Brownell,
A. Kruger,
A. Lister,
P. Hoskin,
M. O'Doherty,
S. Barrington
|
9 |
2015 |
9
๐
|
|
๐
|
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
11 auth.
A. Swerdlow,
C. Higgins,
Paul Smith,
D. Cunningham,
B. Hancock,
A. Horwich,
...
P. Hoskin,
A. Lister,
J. Radford,
A. Rohatiner,
D. Linch
|
8 |
2007 |
8
๐
|
|
๐
|
Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)
18 auth.
D. de Jong,
A. Rosenwald,
M. Chhanabhai,
P. Gaulard,
W. Klapper,
Abigail M. Lee,
B. Sander,
C. Thorns,
E. Campo,
T. Molina,
...
A. Norton,
A. Hagenbeek,
S. Horning,
A. Lister,
J. Raemaekers,
R. Gascoyne,
G. Salles,
E. Weller
|
8 |
2007 |
8
๐
|
|
๐
|
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.
21 auth.
G. Salles,
D. de Jong,
W. Xie,
A. Rosenwald,
M. Chhanabhai,
P. Gaulard,
W. Klapper,
M. Calaminici,
B. Sander,
C. Thorns,
...
E. Campo,
T. Molina,
Abigail M. Lee,
M. Pfreundschuh,
S. Horning,
A. Lister,
L. Sehn,
J. Raemaekers,
A. Hagenbeek,
R. Gascoyne,
E. Weller
|
7 |
2011 |
7
๐
|
|
๐
|
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations.
21 auth.
E. Leich,
I. Salaverria,
S. Beรก,
A. Zettl,
George W. Wright,
V. Moreno,
R. Gascoyne,
W. Chan,
R. Braziel,
L. Rimsza,
...
D. Weisenburger,
J. Delabie,
E. Jaffe,
A. Lister,
J. Fitzgibbon,
L. Staudt,
E. Hartmann,
H. Mueller-Hermelink,
E. Campo,
G. Ott,
A. Rosenwald
|
7 |
2007 |
7
๐
|
|
๐
|
Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
31 auth.
E. Bachy,
J. Seymour,
P. Feugier,
F. Offner,
A. Lรณpez-Guillermo,
D. Belada,
L. Xerri,
J. Catalano,
P. Brice,
F. Lemonnier,
Alejandro Martรญn,
O. Casasnovas,
L. Pedersen,
V. Dorvaux,
D. Simpson,
...
S. Leppa,
J. Gabarre,
M. G. da Silva,
S. Glaisner,
L. Ysebaert,
A. Vekhoff,
T. Intragumtornchai,
S. le Gouill,
A. Lister,
J. Estell,
G. Milone,
A. Sonet,
J. Farhi,
H. Zeuner,
H. Tilly,
G. Salles
|
7 |
2019 |
7
๐
|
|
๐
|
Long-term outcomes to fludarabine and rituximab in Waldenstrรถm macroglobulinemia.
14 auth.
S. Treon,
A. Branagan,
L. Ioakimidis,
J. Soumerai,
C. Patterson,
B. Turnbull,
P. Wasi,
C. Emmanouilides,
S. Frankel,
A. Lister,
...
P. Morel,
J. Matous,
S. Gregory,
E. Kimby
|
7 |
2008 |
7
๐
|
|
๐ข
|
Stevens-Johnson syndrome after treatment with rituximab.
S. Lowndes,
A. Darby,
G. Mead,
A. Lister
|
6 |
2002 |
6
๐ข
|
|
๐ฆ
|
Central nervous system lymphoma.
A. Lister,
L. Abrey,
J. Sandlund
|
6 |
2002 |
6
๐ฆ
|
|
๐
|
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.
11 auth.
D. Helbling,
B. Mueller,
N. Timchenko,
A. Hagemeijer,
M. Jotterand,
S. MeyerโMonard,
...
A. Lister,
J. Rowley,
B. Huegli,
M. Fey,
T. Pabst
|
6 |
2004 |
6
๐
|
